Table 2.
Target Age Group | VPD | VC Rates (%) by Year of Vaccine Administration |
% Difference (2020 vs. 2019) | p-Value * | |
---|---|---|---|---|---|
2019 | 2020 | ||||
12 months | Rotavirus | 60.94 (265,168/435,162) |
70.34 (291,017/413,728) |
+9.40 | <0.001 |
24 months | Men B | 68.98 (313,721/454,775) |
66.30 (288,154/434,596) |
−2.68 | <0.001 |
Men C | 79.44 (361,288/454,775) |
70.96 (308,371/434,596) |
−8.48 | <0.001 | |
Men ACWY | 46.58 (211,836/454,775) |
51.27 (222,797/434,596) |
+4.69 | <0.001 | |
PNC | 92.00 (418,380/454,775) |
90.58 (393,655/434,596) |
−1.42 | <0.001 | |
13 years | HPV (females) | 60.83 (168,680/277,302) |
58.66 (160,219/273,154) |
−2.17 | <0.001 |
HPV (males) | 44.84 (130,907/291,966) |
46.61 (135,249/290,170) |
+1.77 | <0.001 |
* Chi-square test (2020 vs. 2019); HPV: human papillomavirus; Men B, C, and ACWY: N. meningitidis serogroups B, C, and ACW135Y; PNC: S. pneumoniae; VC: vaccination coverage; VPD: vaccine-preventable disease; data source: data from the Italian Regions/Autonomous Provinces.